Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis
Clinical trial NCT02750592 · COMPLETED
Trial details
- NCT number
- NCT02750592
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-22
- Primary completion
- 2017-07-05
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.